SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-005384
Filing Date
2018-03-13
Accepted
2018-03-13 06:04:51
Documents
91
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apvo-10k_20171231.htm 10-K 2685619
2 EX-10.5 apvo-ex105_281.htm EX-10.5 861674
3 EX-10.7 apvo-ex107_280.htm EX-10.7 57926
4 EX-10.38 apvo-ex1038_189.htm EX-10.38 99799
5 EX-23.1 apvo-ex231_599.htm EX-23.1 6217
6 EX-31.1 apvo-ex311_549.htm EX-31.1 17881
7 EX-31.2 apvo-ex312_548.htm EX-31.2 18056
8 EX-32.1 apvo-ex321_546.htm EX-32.1 10290
9 EX-32.2 apvo-ex322_547.htm EX-32.2 10398
10 GRAPHIC g201803122312372953289.jpg GRAPHIC 36885
  Complete submission text file 0001564590-18-005384.txt   10130716

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT apvo-20171231.xml EX-101.INS 1900402
12 XBRL TAXONOMY EXTENSION SCHEMA apvo-20171231.xsd EX-101.SCH 66362
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apvo-20171231_cal.xml EX-101.CAL 88113
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apvo-20171231_def.xml EX-101.DEF 189243
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20171231_lab.xml EX-101.LAB 487204
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20171231_pre.xml EX-101.PRE 381916
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37746 | Film No.: 18685172
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1